Acute Myeloid Leukemia Symptoms

Acute myeloid leukemia (AML) is a subtype of leukemia in which immature blood cells fail to mature and therefore fail to carry out their normal functions.

This disease also goes by the following very similar-sounding names:

  • Acute myelogenous leukemia
  • Acute myelocytic leukemia
  • Acute myeloblastic leukemia
  • Acute granulocytic leukemia

Acute Myeloid Leukemia Symptoms

Most of the symptoms associated with acute myeloid leukemia are known as "non-specific symptoms," meaning that they are not exclusive to this disease. Having one of them does not mean a person has AML. Rather, these non-specific symptoms can be found in a host of other diseases and disorders:

  • Pale skin
  • Unexplained bruising
  • Petechiae (pinhead-size red spots) under the skin
  • An inability or staggered ability to heal from minor cuts
  • Fatigue, lack of energy
  • Shortness of breath when carrying out normal everyday things
  • Mild unexplained fever
  • Night sweats
  • Swollen gums
  • Frequent minor infections
  • Unexplained loss of appetite, subsequent weight loss
  • Aching in bones or joints
  • Discomfort coming from the upper left side of the stomach

This last symptom might indicate a swollen spleen, something a doctor can determine through clinical exam.

A host of these symptoms does not mean one has developed acute myeloid leukemia. Following an exam by a physician, a patient suspected of having AML will likely require some blood tests, a bone marrow biopsy, and finally, confirmation from a pathologist, who uses several lab techniques to determine the specifics of a cancer.

There are approximately 14,000 new diagnoses of AML in the United States each year. It is generally a disease that affects older people, since the median age at diagnosis is 66. It is an aggressive disease that requires immediate treatment following diagnosis.

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap